Management of Urge Incontinence

Introduction to Urge Incontinence Treatment

The American College of Physicians recommends bladder training as the first-line treatment for urgency urinary incontinence, before considering any pharmacotherapy, with a focus on lifestyle modifications such as weight loss and exercise for obese patients, as well as fluid management and caffeine reduction 1, 2, 3

Bladder training is the mandatory first step for urgency urinary incontinence, with concurrent weight loss and exercise for obese patients, and fluid management and caffeine reduction, aiming to reduce urinary incontinence symptoms 1, 2, 3
For patients who are obese, implementing weight loss and exercise concurrently with bladder training is recommended, as these interventions effectively reduce urinary incontinence symptoms 1, 2

Tolterodine or darifenacin are the optimal first-line medications for elderly females with urge incontinence, due to their discontinuation rates similar to placebo and superior tolerability profiles 1, 2
Solifenacin is associated with the lowest risk for discontinuation due to adverse effects among antimuscarinics, with a number needed to treat for benefit (NNTB) of 9 for achieving continence 1, 3
Mirabegron (beta-3 agonist) offers a different mechanism with significantly lower anticholinergic side effects and lower risk of cognitive effects, particularly important in patients over 60 1, 3

Oxybutynin must be avoided as it has the highest discontinuation rate due to adverse effects, with a number needed to harm (NNTH) of 14-16, and is associated with significant cognitive impairment in elderly patients 1, 2
Fesoterodine has poor tolerability with an NNTH for adverse effects of only 7 1

The diagnosis of urge incontinence should be confirmed, characterized by urgency, frequency, and nocturia, rather than stress incontinence, which is leakage with physical activity, before initiating treatment 4, 2
Bladder training should be initiated for 4-8 weeks as the first step in managing urge incontinence 1, 3, 2
If bladder training fails, pharmacotherapy should be selected based on the patient's medication regimen, with tolterodine or darifenacin preferred for patients taking fewer than 7 medications, and mirabegron considered for those concerned about anticholinergic effects or cognitive impairment 1
Combination therapy with solifenacin 5 mg plus mirabegron 50 mg may be considered if monotherapy fails, offering superior efficacy to monotherapies 3